Covid: two doses of vaccine seem to protect against the Delta variant, the EMA claims

Published by Caroline J. · Updated on 5 July 2021 at 17h31 · Published on 1 July 2021 at 15h46
As the Indian variant is spreading more every day, this Thursday July 1, 2021, the European Medicines Agency claims two doses of vaccine seem to protect against the Delta variant.

There are more and more concerns about the Indian variant spreading everywhere, and especially in Europe. A few days ago, the World Health Organization said the Delta variant was now reported in 85 countries in the world. Furthermore, this July 1, 2021, the WHO’s European office reports Covid-19 case numbers have started to rise again last week in Europe after declining for ten weeks in a row.

Coronavirus : un niveau de transmission "alarmant" en Europe selon l'OMS Coronavirus : un niveau de transmission "alarmant" en Europe selon l'OMS Coronavirus : un niveau de transmission "alarmant" en Europe selon l'OMS Coronavirus : un niveau de transmission "alarmant" en Europe selon l'OMS Covid: new case numbers in Europe rising again, WHO warns
The coronavirus epidemic once again takes Europe into fear of mass contaminations WHO considers there will be "a new wave in the WHO European region unless we remain disciplined". After declining for ten weeks in a row, as countries have already started to economically exit lcokdown, new case tolls are increasing in the Old Continent. [Read more]

Therefore, is the Delta variant to be held responsible for this increase in new cases? Should we be worried about the spread of this Indian strain in Europe? Are vaccines effective against this strain? This Thursday July 1, the European Medicines Agency announced two doses of vaccine seem to protect against the Delta variant. “It seems that the 4 vaccines [authorized] in the EU protect against all strains, including the delta variant”, the EMA claimed this Thursday.

 

But, the European Medicines Agency cannot yet assess the effectiveness of two doses of two different vaccines as they lack data made available to date. Nonetheless, “interim results from studies in [Spain, Germany and the UK] show good immune response & no safety concerns”, the EMA added.

Practical information

Comments
Refine your search
Refine your search
Refine your search
Refine your search